Advertisement

Lasers and Related Technologies

  • Robert AnolikEmail author
  • Roy G. Geronemus
Chapter

Abstract

When Albert Einstein first developed the concept of laser radiation in The Quantum Theory of Radiation, none could have predicted all its future roles in the applied sciences [1]. Since that time, physicians have used lasers along with other components of the electromagnetic spectrum in a variety of medical and cosmetic applications. In part because of accessibility, many of these developments have involved the skin and eyes.

Keywords

Actinic Keratose Intense Pulse Light Carbon Dioxide Laser Fractional Laser Congenital Melanocytic Nevus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Einstein A. Zur quantentheorie der strahlung. Physiol Z. 1917;18:121–8.Google Scholar
  2. 2.
    Maiman TH. Stimulated optical radiation in ruby. Nature. 1960;187:493–4.CrossRefGoogle Scholar
  3. 3.
    Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220(4596):524–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics. 1976;58(2):218–22.PubMedGoogle Scholar
  5. 5.
    Jacobs AH. Strawberry hemangiomas; the natural history of the untreated lesion. Calif Med. 1957;86(1):8–10.PubMedCentralPubMedGoogle Scholar
  6. 6.
    Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg. 1983;18(6):894–900.PubMedCrossRefGoogle Scholar
  7. 7.
    Waner M, North PE, Scherer KA, Frieden IJ, Waner A, Mihm Jr MC. The nonrandom distribution of facial hemangiomas. Arch Dermatol. 2003;139(7):869–75.PubMedCrossRefGoogle Scholar
  8. 8.
    Ceisler E, Blei F. Ophthalmic issues in hemangiomas of infancy. Lymphat Res Biol. 2003;1(4):321–30.PubMedCrossRefGoogle Scholar
  9. 9.
    Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg. 2000;37(8):517–84.PubMedCrossRefGoogle Scholar
  10. 10.
    Hunzeker CM, Geronemus RG. Treatment of superficial infantile hemangiomas of the eyelid using the 595-nm pulsed dye laser. Dermatol Surg. 2010;36(5):590–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Batta K, Goodyear HM, Moss C, Williams HC, Hiller L, Waters R. Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis. Lancet. 2002;360(9332):521–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Holy A, Geronemus RG. Treatment of periorbital port-wine stains with the flashlamp-pumped pulsed dye laser. Arch Ophthalmol. 1992;110(6):793–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Barsky SH, Rosen S, Geer DE, Noe JM. The nature and evolution of port wine stains: a computer-assisted study. J Invest Dermatol. 1980;74(3):154–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Geronemus RG, Ashinoff R. The medical necessity of evaluation and treatment of port-wine stains. J Dermatol Surg Oncol. 1991;17(1):76–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Faurschou A, Togsverd-Bo K, Zachariae C, Haedersdal M. Pulsed dye laser vs. intense pulsed light for port-wine stains: a randomized side-by-side trial with blinded response evaluation. Br J Dermatol. 2009;160(2):359–64.PubMedCrossRefGoogle Scholar
  16. 16.
    Izikson L, Nelson JS, Anderson RR. Treatment of hypertrophic and resistant port wine stains with a 755 nm laser: a case series of 20 patients. Lasers Surg Med. 2009;41(6):427–32.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Chapas AM, Eickhorst K, Geronemus RG. Efficacy of early treatment of facial port wine stains in newborns: a review of 49 cases. Lasers Surg Med. 2007;39(7):563–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Renfro L, Geronemus RG. Anatomical differences of port-wine stains in response to treatment with the pulsed dye laser. Arch Dermatol. 1993;129(2):182–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Bagazgoitia L, Boixeda P, Lopez-Caballero C, Bea S, Santiago JL, Jaen P. Venous malformation of the eyelid treated with pulsed-dye-1064-nm neodymium yttrium aluminum garnet sequential laser: an effective and safe treatment. Ophthal Plast Reconstr Surg. 2008;24(6):488–90.PubMedCrossRefGoogle Scholar
  20. 20.
    Hare McCoppin HH, Goldberg DJ. Laser treatment of facial telangiectases: an update. Dermatol Surg. 2010;36(8):1221–30.PubMedCrossRefGoogle Scholar
  21. 21.
    Dawn G, Gupta G. Comparison of potassium titanyl phosphate vascular laser and hyfrecator in the treatment of vascular spiders and cherry angiomas. Clin Exp Dermatol. 2003;28(6):581–3.PubMedCrossRefGoogle Scholar
  22. 22.
    Lai SW, Goldman MP. Treatment of facial reticular veins with dynamically cooled, variable spot-sized 1064 nm Nd:YAG laser. J Cosmet Dermatol. 2007;6(1):6–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Clark C, Cameron H, Moseley H, Ferguson J, Ibbotson SH. Treatment of superficial cutaneous vascular lesions: experience with the KTP 532 nm laser. Lasers Med Sci. 2004;19(1):1–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Sud AR, Tan ST. Pyogenic granuloma-treatment by shave-excision and/or pulsed-dye laser. J Plast Reconstr Aesthet Surg. 2010;63(8):1364–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Karen JK, Hale EK, Geronemus RG. A simple solution to the common problem of ecchymosis. Arch Dermatol. 2010;146(1):94–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Rhodes AR, Albert LS, Barnhill RL, Weinstock MA. Sun-induced freckles in children and young adults. A correlation of clinical and histopathologic features. Cancer. 1991;67(7):1990–2001.PubMedCrossRefGoogle Scholar
  27. 27.
    Taylor CR, Anderson RR. Treatment of benign pigmented epidermal lesions by Q-switched ruby laser. Int J Dermatol. 1993;32(12):908–12.PubMedCrossRefGoogle Scholar
  28. 28.
    Ashinoff R, Geronemus RG. Q-switched ruby laser treatment of labial lentigos. J Am Acad Dermatol. 1992;27(5 Pt 2):809–11.PubMedCrossRefGoogle Scholar
  29. 29.
    Shimbashi T, Kamide R, Hashimoto T. Long-term follow-up in treatment of solar lentigo and cafe-au-lait macules with Q-switched ruby laser. Aesthet Plast Surg. 1997;21(6):445–8.CrossRefGoogle Scholar
  30. 30.
    Kagami S, Asahina A, Watanabe R, et al. Treatment of 153 Japanese patients with Q-switched alexandrite laser. Lasers Med Sci. 2007;22(3):159–63.PubMedCrossRefGoogle Scholar
  31. 31.
    Levy JL, Mordon S, Pizzi-Anselme M. Treatment of individual cafe au lait macules with the Q-switched Nd:YAG: a clinicopathologic correlation. J Cutan Laser Ther. 1999;1(4):217–23.PubMedCrossRefGoogle Scholar
  32. 32.
    Gold MH, Foster TD, Bell MW. Nevus spilus successfully treated with an intense pulsed light source. Dermatol Surg. 1999;25(3):254–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Teekhasaenee C, Ritch R, Rutnin U, Leelawongs N. Ocular findings in oculodermal melanocytosis. Arch Ophthalmol. 1990;108(8):1114–20.PubMedCrossRefGoogle Scholar
  34. 34.
    Lowe NJ, Wieder JM, Sawcer D, Burrows P, Chalet M. Nevus of Ota: treatment with high energy fluences of the Q-switched ruby laser. J Am Acad Dermatol. 1993;29(6):997–1001.PubMedCrossRefGoogle Scholar
  35. 35.
    Chan HH, Ying SY, Ho WS, Kono T, King WW. An in vivo trial comparing the clinical efficacy and complications of Q-switched 755 nm alexandrite and Q-switched 1064 nm Nd:YAG lasers in the treatment of nevus of Ota. Dermatol Surg. 2000;26(10):919–22.PubMedCrossRefGoogle Scholar
  36. 36.
    Tse Y, Levine VJ, McClain SA, Ashinoff R. The removal of cutaneous pigmented lesions with the Q-switched ruby laser and the Q-switched neodymium: yttrium-aluminum-garnet laser. A comparative study. J Dermatol Surg Oncol. 1994;20(12):795–800.PubMedCrossRefGoogle Scholar
  37. 37.
    Wang HW, Liu YH, Zhang GK, et al. Analysis of 602 Chinese cases of nevus of Ota and the treatment results treated by Q-switched alexandrite laser. Dermatol Surg. 2007;33(4):455–60.PubMedCrossRefGoogle Scholar
  38. 38.
    Chan HH, Lam LK, Wong DS, et al. Nevus of Ota: a new classification based on the response to laser treatment. Lasers Surg Med. 2001;28(3):267–72.PubMedCrossRefGoogle Scholar
  39. 39.
    Dohil MA, Baugh WP, Eichenfield LF. Vascular and pigmented birthmarks. Pediatr Clin North Am. 2000;47(4):783–812, v–vi.PubMedCrossRefGoogle Scholar
  40. 40.
    Swerdlow AJ, English JS, Qiao Z. The risk of melanoma in patients with congenital nevi: a cohort study. J Am Acad Dermatol. 1995;32(4):595–9.PubMedCrossRefGoogle Scholar
  41. 41.
    Soden CE, Smith K, Skelton H. Histologic features seen in changing nevi after therapy with an 810 nm pulsed diode laser for hair removal in patients with dysplastic nevi. Int J Dermatol. 2001;40(8):500–4.PubMedCrossRefGoogle Scholar
  42. 42.
    Lim JY, Jeong Y, Whang KK. A Combination of dual-mode 2,940 nm Er:YAG laser ablation with surgical excision for treating medium-sized congenital melanocytic nevus. Ann Dermatol. 2009;21(2):120–4.PubMedCentralPubMedCrossRefGoogle Scholar
  43. 43.
    Rajpar SF, Abdullah A, Lanigan SW. Er:YAG laser resurfacing for inoperable medium-sized facial congenital melanocytic naevi in children. Clin Exp Dermatol. 2007;32(2):159–61.PubMedCrossRefGoogle Scholar
  44. 44.
    Kishi K, Okabe K, Ninomiya R, et al. Early serial Q-switched ruby laser therapy for medium-sized to giant congenital melanocytic naevi. Br J Dermatol. 2009;161(2):345–52.PubMedCrossRefGoogle Scholar
  45. 45.
    Anderson RR, Geronemus R, Kilmer SL, Farinelli W, Fitzpatrick RE. Cosmetic tattoo ink darkening. A complication of Q-switched and pulsed-laser treatment. Arch Dermatol. 1993;129(8):1010–4.PubMedCrossRefGoogle Scholar
  46. 46.
    Geronemus RG. Surgical pearl: Q-switched Nd:YAG laser removal of eyeliner tattoo. J Am Acad Dermatol. 1996;35(1):101–2.PubMedCrossRefGoogle Scholar
  47. 47.
    Mafong EA, Kauvar AN, Geronemus RG. Surgical pearl: removal of cosmetic lip-liner tattoo with the pulsed carbon dioxide laser. J Am Acad Dermatol. 2003;48(2):271–2.PubMedCrossRefGoogle Scholar
  48. 48.
    Brightman LA, Brauer JA, Anolik R, et al. Ablative and fractional ablative lasers. Dermatol Clin. 2009;27(4):479–89, vi–vii.PubMedCrossRefGoogle Scholar
  49. 49.
    Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004;34(5):426–38.PubMedCrossRefGoogle Scholar
  50. 50.
    Sukal SA, Chapas AM, Bernstein LJ, Hale EK, Kim KH, Geronemus RG. Eyelid tightening and improved eyelid aperture through nonablative fractional resurfacing. Dermatol Surg. 2008;34(11):1454–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Geronemus RG. Fractional photothermolysis: current and future applications. Lasers Surg Med. 2006;38(3):169–76.PubMedCrossRefGoogle Scholar
  52. 52.
    Kotlus BS. Dual-depth fractional carbon dioxide laser resurfacing for periocular rhytidosis. Dermatol Surg. 2010;36(5):623–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Kunishige JH, Katz TM, Goldberg LH, Friedman PM. Fractional photothermolysis for the treatment of surgical scars. Dermatol Surg. 2010;36(4):538–41.PubMedCrossRefGoogle Scholar
  54. 54.
    Behroozan DS, Goldberg LH, Dai T, Geronemus RG, Friedman PM. Fractional photothermolysis for the treatment of surgical scars: a case report. J Cosmet Laser Ther. 2006;8(1):35–8.PubMedCrossRefGoogle Scholar
  55. 55.
    Weiss ET, Chapas A, Brightman L, et al. Successful treatment of atrophic postoperative and traumatic scarring with carbon dioxide ablative fractional resurfacing: quantitative volumetric scar improvement. Arch Dermatol. 2010;146(2):133–40.PubMedCrossRefGoogle Scholar
  56. 56.
    Fitzpatrick R, Geronemus R, Goldberg D, Kaminer M, Kilmer S, Ruiz-Esparza J. Multicenter study of noninvasive radiofrequency for periorbital tissue tightening. Lasers Surg Med. 2003;33(4):232–42.PubMedCrossRefGoogle Scholar
  57. 57.
    Ruiz-Esparza J. Noninvasive lower eyelid blepharoplasty: a new technique using nonablative radiofrequency on periorbital skin. Dermatol Surg. 2004;30(2 Pt 1):125–9.PubMedCrossRefGoogle Scholar
  58. 58.
    Biesman BS, Baker SS, Carruthers J, Silva HL, Holloman EL. Monopolar radiofrequency treatment of human eyelids: a prospective, multicenter, efficacy trial. Lasers Surg Med. 2006;38(10):890–8.PubMedCrossRefGoogle Scholar
  59. 59.
    Friedman DJ, Gilead LT. The use of hybrid radiofrequency device for the treatment of rhytides and lax skin. Dermatol Surg. 2007;33(5):543–51.PubMedCrossRefGoogle Scholar
  60. 60.
    Biesman BS, Pope K. Monopolar radiofrequency treatment of the eyelids: a safety evaluation. Dermatol Surg. 2007;33(7):794–801.PubMedCrossRefGoogle Scholar
  61. 61.
    Geronemus RG, Chapas AM, Desai S, Brightman L, Hale EK, Karen JK, Bernstein LJ. Finally! A well-tolerated and effective treatment for actinic keratoses on the face. American Society for Laser Medicine and Surgery 30th Annual Conference. Phoenix, 2010.Google Scholar
  62. 62.
    Epstein JS. Management of infraorbital dark circles. A significant cosmetic concern. Arch Facial Plast Surg. 1999;1(4):303–7.PubMedCrossRefGoogle Scholar
  63. 63.
    Roh MR, Chung KY. Infraorbital dark circles: definition, causes, and treatment options. Dermatol Surg. 2009;35(8):1163–71.PubMedCrossRefGoogle Scholar
  64. 64.
    Watanabe S, Nakai K, Ohnishi T. Condition known as “dark rings under the eyes” in the Japanese population is a kind of dermal melanocytosis which can be successfully treated by Q-switched ruby laser. Dermatol Surg. 2006;32(6):785–9, discussion 789.PubMedCrossRefGoogle Scholar
  65. 65.
    Momosawa A, Kurita M, Ozaki M, et al. Combined therapy using Q-switched ruby laser and bleaching treatment with tretinoin and hydroquinone for periorbital skin hyperpigmentation in Asians. Plast Reconstr Surg. 2008;121(1):282–8.PubMedCrossRefGoogle Scholar
  66. 66.
    West TB, Alster TS. Improvement of infraorbital hyperpigmentation following carbon dioxide laser resurfacing. Dermatol Surg. 1998;24(6):615–6.PubMedCrossRefGoogle Scholar
  67. 67.
    Bergman R. The pathogenesis and clinical significance of xanthelasma palpebrarum. J Am Acad Dermatol. 1994;30(2 Pt 1):236–42.PubMedCrossRefGoogle Scholar
  68. 68.
    Rohrich RJ, Janis JE, Pownell PH. Xanthelasma palpebrarum: a review and current management principles. Plast Reconstr Surg. 2002;110(5):1310–4.PubMedCrossRefGoogle Scholar
  69. 69.
    Alster TS, West TB. Ultrapulse CO2 laser ablation of xanthelasma. J Am Acad Dermatol. 1996;34(5 Pt 1):848–9.PubMedCrossRefGoogle Scholar
  70. 70.
    Borelli C, Kaudewitz P. Xanthelasma palpebrarum: treatment with the erbium:YAG laser. Lasers Surg Med. 2001;29(3):260–4.PubMedCrossRefGoogle Scholar
  71. 71.
    Karsai S, Czarnecka A, Raulin C. Treatment of xanthelasma palpebrarum using a pulsed dye laser: a prospective clinical trial in 38 cases. Dermatol Surg. 2010;36(5):610–7.PubMedCrossRefGoogle Scholar
  72. 72.
    Karsai S, Schmitt L, Raulin C. Is Q-switched neodymium-doped yttrium aluminium garnet laser an effective approach to treat xanthelasma palpebrarum? Results from a clinical study of 76 cases. Dermatol Surg. 2009;35(12):1962–9.PubMedCrossRefGoogle Scholar
  73. 73.
    Raulin C, Schoenermark MP, Werner S, Greve B. Xanthelasma palpebrarum: treatment with the ultrapulsed CO2 laser. Lasers Surg Med. 1999;24(2):122–7.PubMedCrossRefGoogle Scholar
  74. 74.
    Fusade T. Treatment of xanthelasma palpebrarum by 1064-nm Q-switched Nd:YAG laser: a study of 11 cases. Br J Dermatol. 2008;158(1):84–7.PubMedGoogle Scholar
  75. 75.
    Katz TM, Goldberg LH, Friedman PM. Fractional photothermolysis: a new therapeutic modality for xanthelasma. Arch Dermatol. 2009;145(10):1091–4.PubMedCrossRefGoogle Scholar
  76. 76.
    Grossman MC, Dierickx C, Farinelli W, Flotte T, Anderson RR. Damage to hair follicles by normal-mode ruby laser pulses. J Am Acad Dermatol. 1996;35(6):889–94.PubMedCrossRefGoogle Scholar
  77. 77.
    Toosi P, Sadighha A, Sharifian A, Razavi GM. A comparison study of the efficacy and side effects of different light sources in hair removal. Lasers Med Sci. 2006;21(1):1–4.PubMedCrossRefGoogle Scholar
  78. 78.
    Moore J, De Silva SR, O’Hare K, Humphry RC. Ruby laser for the treatment of trichiasis. Lasers Med Sci. 2009;24(2):137–9.PubMedCrossRefGoogle Scholar
  79. 79.
    Patrizi A, Neri I, Marzaduri S, Varotti E, Passarini B. Syringoma: a review of twenty-nine cases. Acta Derm Venereol. 1998;78(6):460–2.PubMedCrossRefGoogle Scholar
  80. 80.
    Smith JD, Chernosky ME. Hidrocystomas. Arch Dermatol. 1973;108(5):676–9.PubMedCrossRefGoogle Scholar
  81. 81.
    Wang JI, Roenigk Jr HH. Treatment of multiple facial syringomas with the carbon dioxide (CO2) laser. Dermatol Surg. 1999;25(2):136–9.PubMedCrossRefGoogle Scholar
  82. 82.
    Riedel F, Windberger J, Stein E, Hormann K. Treatment of peri-ocular skin lesions with the erbium:YAG laser. Ophthalmologe. 1998;95(11):771–5.PubMedCrossRefGoogle Scholar
  83. 83.
    Tanzi E, Alster TS. Pulsed dye laser treatment of multiple eccrine hidrocystomas: a novel approach. Dermatol Surg. 2001;27(10):898–900.PubMedCrossRefGoogle Scholar
  84. 84.
    Choi JE, Ko NY, Son SW. Lack of effect of the pulsed-dye laser in the treatment of multiple eccrine hidrocystomas: a report of two cases. Dermatol Surg. 2007;33(12):1513–5.PubMedGoogle Scholar
  85. 85.
    Madan V, August PJ, Ferguson J. Multiple eccrine hidrocystomas – response to treatment with carbon dioxide and pulsed dye lasers. Dermatol Surg. 2009;35(6):1015–7.PubMedCrossRefGoogle Scholar
  86. 86.
    Park HJ, Lee DY, Lee JH, Yang JM, Lee ES, Kim WS. The treatment of syringomas by CO(2) laser using a multiple-drilling method. Dermatol Surg. 2007;33(3):310–3.PubMedCrossRefGoogle Scholar
  87. 87.
    Park HJ, Lim SH, Kang HA, Byun DG, Houh D. Temporary tattooing followed by Q-switched alexandrite laser for treatment of syringomas. Dermatol Surg. 2001;27(1):28–30.PubMedCrossRefGoogle Scholar
  88. 88.
    Gupta S, Handa U, Handa S, Mohan H. The efficacy of electrosurgery and excision in treating patients with multiple apocrine hidrocystomas. Dermatol Surg. 2001;27(4):382–4.PubMedCrossRefGoogle Scholar
  89. 89.
    Al Aradi IK. Periorbital syringoma: a pilot study of the efficacy of low-voltage electrocoagulation. Dermatol Surg. 2006;32(10):1244–50.PubMedCrossRefGoogle Scholar
  90. 90.
    Hammes S, Augustin A, Raulin C, Ockenfels HM, Fischer E. Pupil damage after periorbital laser treatment of a port-wine stain. Arch Dermatol. 2007;143(3):392–4.PubMedCrossRefGoogle Scholar
  91. 91.
    Halkiadakis I, Skouriotis S, Stefanaki C, et al. Iris atrophy and posterior synechiae as a complication of eyebrow laser epilation. J Am Acad Dermatol. 2007;57(2 Suppl):S4–5.PubMedCrossRefGoogle Scholar
  92. 92.
    Le Jeune M, Autie M, Monnet D, Brezin AP. Ocular complications after laser epilation of eyebrows. Eur J Dermatol. 2007;17(6):553–4.PubMedGoogle Scholar
  93. 93.
    Shulman S, Bichler I. Ocular complications of laser-assisted eyebrow epilation. Eye (Lond). 2009;23(4):982–3.CrossRefGoogle Scholar
  94. 94.
    Pham RT, Tzekov RT, Biesman BS, Marmor MF. Retinal evaluation after 810 nm Dioderm laser removal of eyelashes. Dermatol Surg. 2002;28(9):836–40.PubMedCrossRefGoogle Scholar
  95. 95.
    Fretzin S, Beeson WH, Hanke CW. Ignition potential of the 585-nm pulsed-dye laser. Review of the literature and safety recommendations. Dermatol Surg. 1996;22(8):699–702.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Laser & Skin Surgery Center of New YorkNew YorkUSA

Personalised recommendations